RxDoctor Payments Data

Arya Varthi, MD

Orthopaedic Surgery · New Haven, CTNPI 1114218757

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Medical Device Business Services, Inc. at 49.2% of the total.

$28,090in general payments, 2019–2025

Across 200 payments — averaging $140.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$14K
  • Alphatec Spine, Inc$4K
  • Depuy Synthes Products, Inc.$3K
  • Johnson & Johnson$3K
  • Globus Medical$2K
  • Si-bone, Inc.$1K
  • plus $1K from 7 others
$19,210in research payments, 2019–2025

Across 3 payments — averaging $6403.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Tanabe Pharma America, Inc.$19K

What the payments were for

  • Consulting fees$11,62341%
  • Travel & lodging$9,20233%
  • Food & beverage$7,26526%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,090 in reported general payments places this provider in the 80th percentile of 273 orthopaedic surgery providers in Connecticut.

See all orthopaedic surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$83,815
Medicare patients
196
Services billed
415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl44$231
Gabapentin20$195
Oxycodone Hcl22$156
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$134
Methocarbamol11$101
Tramadol Hcl19$89
Tizanidine Hcl12$24
Meloxicam14$11

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →